Dexamethasone Halts Rare Complication of Type 1 Diabetes


By: Ben Eastman

A new treatment method has been discovered for lipoatrophy, a rare but problematic complication of type 1 diabetes. The condition is an adverse effect of the immune system’s interaction with insulin that results in dents in the skin at insulin injection sites. These dents are caused by atrophy of the tissue directly beneath the skin.

Insulin is known to produce allergic and immunological reactions in some people. In such a reaction, the body’s immune system attacks the foreign substance, like it would a disease-causing bacteria.

Lipoatrophy is an example of this type of immune system response. It includes the production of cytokines, proteins that work as mediators between the cells in the “infected” area and help generate the response.

In a study published in the November 1996 issue of Diabetes Care researchers hypothesized that the cytokines might also cause the tissue atrophy at injection sites. In laboratory experiments researchers found that dexamethasone, an anti-inflammatory medication, inhibited the production of cytokines.

After these laboratory findings, dexamethasone was used on a 25-year-old woman with lipoatrophy on her arms, abdomen and hips. A mixture of insulin and dexamethasone was injected directly into her lipoatrophic injection sites. This treatment had no effect on the patient’s metabolic control and her daily insulin requirements did not change. After 12 months of treatment, all of her lipoatrophic areas disappeared.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.